Key Points Viking Therapeutics' stock dropped after a capital raise, not due to trial results. The company raised more capital than initially planned, indicating strong demand. 10 stocks we like better than Viking Therapeutics › Viking Therapeutics (NASDAQ: VKTX) stock declined by 14.5% in early morning trading today, a week after the company reported top-line results from a maintenance study of its key weight-loss drug, VK2735. However, don't panic. Today's move is not directly related to the results released a couple of days ago.
Chung toi hien cong khai y chinh. Tao tai khoan mien phi de doc toan bo bai viet, luu, thao luan va ket noi voi boi canh thi truong va OSINT.